Skip to main content
SpringerLink
Log in

Fluoroquinolones cost effective in prevention of MDR-TB

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2014 US dollars

Reference

  • Fox GJ, et al. Fluoroquinolone Therapy for the Prevention of Multi-drug Resistant Tuberculosis in Contacts: a Cost-effectiveness Analysis. American Journal of Respiratory and Critical Care Medicine : 27 Apr 2015. Available from: URL: http://doi.org/10.1164/rccm.201501-0069OC

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fluoroquinolones cost effective in prevention of MDR-TB. PharmacoEcon Outcomes News 727, 14 (2015). https://doi.org/10.1007/s40274-015-2098-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2098-6

Search

Navigation